Most Clicked StoriesMore >


N.Y. attorney general sues over switch to new drug

FDLI SmartBrief | Sep 16, 2014

A federal antitrust lawsuit filed by New York State Attorney General Eric Schneiderman says Forest Laboratories is attempting to move patients to a newer version of its Alzheimer's drug to dodge generic competition. "A drug company manipulating vulnerable patients and forcing physicians to alter treatment plans unnecessarily, simply to protect corporate profits, is unethical and illegal," Schneiderman said. A representative of Actavis, which now owns Forest, said the company does not comment on pending lawsuits. New York Times (tiered subscription model), The (09/16)


FDA to expedite review of Shire's Vyvanse for eating disorder

FDLI SmartBrief | Sep 16, 2014

White House bolsters fight against antibiotic-resistant bacteria

FDLI SmartBrief | Sep 19, 2014

Stricter labels for testosterone drugs backed by FDA panel

FDLI SmartBrief | Sep 18, 2014

FDA committees to examine potential heart risks of testosterone treatments

FDLI SmartBrief | Sep 17, 2014

Lawmakers debate limits on trials for some Ebola drug candidates

FDLI SmartBrief | Sep 18, 2014

Lawmaker urges FDA to restrict agricultural antibiotics

FDLI SmartBrief | Sep 16, 2014

FDLI and Harvard Law partnering on academic symposium: Emerging Issues and New Frontiers for FDA Regulation, Oct. 20

FDLI SmartBrief | Sep 16, 2014

Baxter-Halozyme immunodeficiency drug HyQvia gains FDA approval

FDLI SmartBrief | Sep 15, 2014

FDA panel's support for OIC drugs' safety praised by experts

FDLI SmartBrief | Sep 15, 2014


Find FDLI SmartBrief Issues by Date:



FDLI News More >


Second Annual Blumberg Memorial Lecture: Enforcement, Litigation and Compliance Conference, Dec. 8-9

FDLI SmartBrief | Sep 22, 2014

Brussels Conference: New speakers confirmed for Food Labeling & Health Claims, Nov. 13-14

FDLI SmartBrief | Sep 22, 2014

FDLI & USP: Current Issues: Implementation of Pharmaceutical Drug Laws and Regulations by the Food and Drug Administration (FDA)

FDLI SmartBrief | Sep 19, 2014

Food Advertising Conference -- Regulatory developments with GMOs, New York, Oct. 8

FDLI SmartBrief | Sep 19, 2014

Spotlight panel: Quality Control Issues in the U.S. and EU -- Drugs and Devices -- Brussels Conference, Nov. 13-14

FDLI SmartBrief | Sep 18, 2014




Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Recent Poll view more polls


What affect do you think this year's media focus on imported drug, food and medical device product safety will have in 2010?

Chart.